NEW YORK (GenomeWeb News) — Roche said today that it has licensed its emulsion PCR patent portfolio to Sysmex Inostics.

Under the agreement, Sysmex Inostics receives a worldwide, non-exclusive, royalty-bearing license to Roche's patents covering emPCR, a technique in which individual DNA molecules are isolated in discrete water/oil emulsions including a capture bead and PCR amplification reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.